top of page
Browse by category
Search
Preoperative antihypertensive drugs and visceral fat area can predict hypertension remission and recurrence post-LSG
By combining the number of preoperative antihypertensive drugs (ADs) and visceral fat area (VFA) may help predict hypertension (HTN)...
Muscle-preserving weight loss drug ASC47 plus semaglutide is superior to semaglutide monotherapy for weight loss
Ascletis Pharma has revealed in a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg,...
Racial and ethnic groups face barriers to obtaining OMMs
Asians, non-Hispanic Blacks and Hispanics were significantly less likely than whites to use obesity-management medications (OMMs) to...
Survey finds 50% of post-bariatric surgery patients feel less stress during the holidays
About 50% of bariatric patients reported experiencing significantly less or less stress during the holidays compared to the holiday...
Journal Watch 18/12/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
True You Weight Loss to initiate two clinical trials assessing gastric fundal mucosal ablation
True You Weight Loss, a dedicated endobariatric weight loss center, has announced two new FDA-authorised clinical trials aimed at...
Browse by tag
bottom of page